Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Technologies: Start Of Enrollment In Peripheral Lung Cancer Multi-Site Clinical Trial

June 1 (Reuters) - Mauna Kea Technologies Sas  MKEA.PA :
    * MAUNA KEA TECHNOLOGIES ANNOUNCES START OF ENROLLMENT IN
PERIPHERAL LUNG CANCER MULTI-SITE CLINICAL TRIAL COMBINING ION®
WITH CELLVIZIO®
    * ANNOUNCES START OF ENROLLMENT IN PERIPHERAL LUNG CANCER
MULTI-SITE CLINICAL TRIAL COMBINING ION® WITH CELLVIZIO®
    * INITIAL ENROLLMENT OF PATIENTS HAS BEGUN IN A PROSPECTIVE,
RANDOMIZED, TWO-ARM, MULTI-SITE CLINICAL STUDY SPONSORED BY MAYO
CLINIC AND FINANCIALLY SUPPORTED BY MAUNA KEA TECHNOLOGIES.

Source text for Eikon:  ID:nBw5cpWYba 
Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Mauna Kea Technologies SA

See all news